Autor :Lamot, Sebastián Blas 1
1Clínica Conciencia. Neuquén. Hospital Provincial Castro Rendon, Neuquén
Historically, lung
cancer has been diagnosed late, with the well-known ominous consequences (1-2).
Usually, lung cancer detection occurs in specialized hospital units with greater
human and technological resources.
As
described in the article “Analysis of Lung Cancer in a Reference
Hospital in the City of Santa Fe with
a Follow-Up of 20 years”
and in many other publications, there have been epidemiological
changes in recent years. There has been a modification in the histology of the most common
presentation (an increase in adenocarcinoma), a shift
in prevalence between genders (an increase
in women and a decrease in men), and a decrease in smoking incidence. However, at the time of diagnosis, non-surgical
stages account for over 70%. There
is already sufficient evidence that early detection
programs using tomography improve survival rates and enable early diagnosis of cancer. However, there are many difficulties for people to access these programs (4-7). While there is
acceptance among the majority of involved specialties (8)
and consensus from scientific societies (9),
there may still be a lack of health policies aimed at changing this situation.
If we want to take measures
that reach the entire population,
we cannot expect to do so solely through large centers. In my opinion, primary
care networks with increasing levels of complexity are the key to reaching
asymptomatic patients. It is also
important to have coordination with a higher complexity center for case discussions and the adoption of best practices. Early detection healthcare providers should not only
serve as referrals but also be an
integral part of the project. Smoking cessation is an essential
component of any program and could have a place in this level of care.
I
think that we should form
interdisciplinary working groups to implement the early detection
program for lung cancer and ultimately improve the survival rates
of this disease.
REFERENCES
1.
Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging
Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
J Thorac Oncol. 2016;11:39-51. https://doi.org/10.1016/j.jtho.2015.09.009
2.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates
of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.
https://doi.org/10.3322/caac.21660
3.
Vegetti L, Ballina A, Wustten
S, et al. Implementation of a COPD Eradication Program Multidisciplinary Program for Prevention, Diagnosis, and
Management of Pre-COPD Rev Am Med
Resp 2023;23:89-104.
https://doi.org/10.56538/ramr.NCNG2904
4.
National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed
tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. https://doi.org/10.1056/NEJMoa1102873.
5.
de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
N Engl J Med. 2020;382:503-13. https://doi.org/10.1056/NEJMoa1911793.
6.
Pastorino U, Silva M, Sestini
S, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation
of lung cancer screening efficacy. Ann Oncol. 2019;30:1672. https://doi.org/10.1093/annonc/mdz169.
7.
Santos RS, Franceschini JP, Chate RC, et al. Do Current Lung Cancer Screening
Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the
First Brazilian Lung Cancer Screening
Trial (BRELT1). Ann Thorac Surg.
2016;101:481-6. https://doi.org/10.1016/j.athoracsur.2015.07.013.
8.
Lamot S, Viola L, Benitez
S, et al. Current status of Lung
Cancer Screening in Latin America. LALCA 2023. J Thorac Oncol. 2023;18: S29. https://doi.org/10.1016/j.jtho.2023.01.079
9.
Boyeras I, Roberti J, Seijo M, et al. Argentine consensus recommendations for lung cancer screening
programmes: a RAND/ UCLA-modified
Delphi study. BMJ Open 2023;13:e068271.
https://doi.org/10.1136/bmjopen-2022-068271